
Sanguine Transformation Innovatives LLP
About Sanguine Transformation Innovatives LLP
Data last updated:
Sanguine Transformation Innovatives LLP is a limited liability partnership (LLP) based in Pune, Maharashtra, India. It operates in the service-based operations segment of the business services sector. It was incorporated on 12 October 2020 and has been in existence for over 6 years.
The LLP is registered with the Registrar of Companies (ROC), Pune, under LLPIN AAU-2021.
The LLP has a total obligation of contribution of βΉ20,000. It is led by designated partners Tejansh Narayan Chandole and Kochuthresia Anu.
Its latest statement of accounts is for the year ended 31 March 2022. The registered office is at Flat No. 24 A 2 Vitthal Heights S. No. 18/3/1 Anand Nagar Sinhgad Road, Pune, Maharashtra, India β 411051.
Company details
Contact details
Sanguine Transformation Innovatives LLP's registered office is in Pune, Maharashtra.
- Registered AddressFlat No. 24 A 2 Vitthal Heights S. No. 18/3/1 Anand Nagar Sinhgad Road, Pune, Maharashtra, India β 411051
- IndustryBusiness Services, Other Services
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of Sanguine Transformation Innovatives LLP
FY 2022 filings availableFinancial Statement Summary
| Statement of Account and Solvency | FY 2021-22 | FY 2020-21 |
|---|---|---|
| Income and Expenditure | ||
| Turnover | ||
| Other Income | ||
| Total Income | ||
| Purchases and Direct Costs | ||
| Personnel Expenses | ||
| Administrative Expenses | ||
| Interest | ||
| Depreciation | ||
| Total Expenses | ||
| Profit Before Tax | ||
| Tax | ||
| Profit After Tax | ||
| Profit Transferred to Partners | ||
| Assets and Liabilities | ||
| Partners' Contribution | ||
| Reserves and Surplus | ||
| Secured Loans | ||
| Unsecured Loans | ||
| Trade Payables | ||
| Other Liabilities and Provisions | ||
| Total Liabilities | ||
| Fixed Assets | ||
| Investments | ||
| Loans and Advances | ||
| Inventories | ||
| Trade Receivables | ||
| Cash and Bank Balance | ||
| Total Assets | ||
Financial Ratios
| Statement of Account and Solvency | FY 2021-22 | FY 2020-21 |
|---|---|---|
| Profitability | ||
| Net Profit Margin | ||
| Return on Partners' Funds | ||
| Return on Assets | ||
| Liquidity and Debt | ||
| Current Ratio | ||
| Debt to Partners' Funds | ||
| Interest Coverage | ||
| Efficiency and Growth | ||
| Asset Turnover | ||
| Receivable Days | ||
| Turnover Growth | ||
| Profit Growth | ||
To see the full financial statements and ratios of Sanguine Transformation Innovatives LLP, buy the company report.
Designated partners of Sanguine Transformation Innovatives LLP
Sanguine Transformation Innovatives has 2 current designated partners and 1 former designated partner. Current designated partners are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Tejansh Narayan Chandole | Designated Partner | 12 Oct 2020 | 6 Years 0 Months | Current |
| Kochuthresia Anu | Designated Partner | 12 Mar 2025 | 1 Years 7 Months | Current |
Legal cases
No court or tribunal cases involving Sanguine Transformation Innovatives LLP are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Sanguine Transformation Innovatives LLP; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Sanguine Transformation Innovatives LLP; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Sanguine Transformation Innovatives LLP has 4 designated partner changes on record since 2020: 3 appointments and 1 cessation. The latest: Kochuthresia Anu was appointed as Designated Partner on 12 Mar 2025.
Frequently asked questions
Sanguine Transformation Innovatives is an active limited liability partnership based in Pune, Maharashtra, India. The LLP works in other services, within the business services industry. It was incorporated on 12 October 2020 (6+ years old) and is registered under LLPIN AAU-2021.
Sanguine Transformation Innovatives has 2 current designated partners:
- Tejansh Narayan Chandole - Designated Partner
- Kochuthresia Anu - Designated Partner
The latest financial statements of Sanguine Transformation Innovatives on record with the MCA are for the year ended 31 March 2022. Its last annual general meeting was held on 31 March 2025. Year-wise statements from FY 2021 are in the company report.
The LLPIN (Limited Liability Partnership Identification Number) of Sanguine Transformation Innovatives is AAU-2021. It is issued by the Ministry of Corporate Affairs and uniquely identifies the LLP in India.
Sanguine Transformation Innovatives was incorporated on 12 October 2020, making it 6+ years old. It is registered with the Registrar of Companies, Pune.
Kochuthresia Anu was appointed as Designated Partner on 12 Mar 2025. Pankaj Rajesh Madkikar ceased to be Designated Partner on 12 Mar 2025. Pankaj Rajesh Madkikar was appointed as Designated Partner on 12 Oct 2020. Sanguine Transformation Innovatives has 4 designated partner changes on record in total.
The registered office of Sanguine Transformation Innovatives is at Flat No. 24 A 2 Vitthal Heights S. No. 1831 Anand Nagar Sinhgad Road, Pune, Maharashtra, India β 411051.
Sanguine Transformation Innovatives operates in the business services industry, in the other services segment.
Sanguine Transformation Innovatives can be reached at its registered office: Flat No. 24 A 2 Vitthal Heights S. No. 1831 Anand Nagar Sinhgad Road, Pune, Maharashtra, India β 411051.
Sanguine Transformation Innovatives is registered under the jurisdiction of the Registrar of Companies (ROC), Pune.

